AI in Pharmacovigilance: Systems, Agents & Governance · Section 13.12

Summary, Career Implications, and Key References

~4 min read · The Drug Safety Coach — Global PV Career Course

Key points

•AI in PV in 2026 is production reality at scale — six named platforms, seven governance principles, five HITL levels, and a regulatory framework that’s already binding in major jurisdictions
•The consistent pattern across every application: AI handles mechanically intensive, volume-dependent work; humans handle clinically interpretive, regulatory-judgmental, and ethically consequential decisions
•For an entry-level PV professional in 2026, AI literacy is no longer optional — knowing the taxonomy, the named platforms, and the governance framework is now baseline interview fluency, not a specialisation
•The skills AI cannot replace — clinical judgment, causality reasoning, regulatory interpretation, the discipline this entire course has built — are exactly what becomes MORE valuable as the mechanical work gets automated, not less

Listen to this lessonSpeed

Read in:

Full text

This module treated AI in pharmacovigilance the same way this course has treated every other complex subject: not as a single principle to remember, but as a genuine body of knowledge — a taxonomy of six distinct AI types, a stage-by-stage map of what each does across the workflow this course already taught, five named agentic agent types shipping in production, three major platforms with specific, current, citable capabilities, a seven-principle governance framework from the authoritative international body, a five-level spectrum for what "human in the loop" actually means, and a concrete discipline for designing HITL workflows that genuinely work rather than merely appearing to.

For a PV professional entering the field in 2026 or later, this fluency is no longer a specialisation — it’s baseline. An interviewer is increasingly likely to ask not "do you know what AI does in PV" but "walk me through the five HITL levels" or "what does CIOMS WG XIV require for bias testing" — and the difference between a candidate who can answer with this module’s specificity and one who can only gesture vaguely at "AI helps with coding" is exactly the difference this entire course has been built to produce, module after module.

The closing idea worth carrying forward is the one this module returned to at every stage: AI handles volume, humans handle judgment, and that division of labour doesn’t erode the value of everything Modules 1 through 12 built — it sharpens it. As the mechanical work increasingly gets automated, the clinical reasoning, the regulatory interpretation, and the disciplined judgment this course has spent twelve modules building become more valuable, not less, because they’re precisely the part of the system that can’t be automated away.

Key references: PV360 Handbook Ch.13-14, CIOMS Working Group XIV Final Report (December 2025), EU AI Act (Regulation (EU) 2024/1689), FDA-EMA Joint AI Guiding Principles (January 2026), EMA GVP Module IX Rev 2, EMA GVP AI Annex (draft).

Key Concept

"Every module before this one taught you a skill AI can now assist with. This module taught you the one thing that determines whether that assistance makes the system safer or just faster: genuine human judgment, applied at the right point, by someone who actually understands what they’re signing off on. That’s not a skill AI is coming for. It’s the skill that becomes more valuable every time AI gets better at everything around it." — Vinay Kumar

Quick check

Test yourself before moving on — no pressure, just click an answer.

1. According to this module’s closing argument, why does AI automation make human clinical and regulatory judgment MORE valuable rather than less?

See interview questions for this module →

← 13.11 Designing HITL Workflows That Actually WorkComplete this lesson to continue